Specialty Pharmacy

Top news of the day from across the health care landscape.

Population-based screening was found to be associated with a reduction in admissions, physician visits, and prescribed medication for individuals diagnosed with type 2 diabetes.

An HIV primary care program is working to reduce the number of new HIV diagnoses and increase viral suppression rates in Long Island and Queens.

Fingolimod (Gilenya, Novartis) is the first FDA-approved treatment to treat multiple sclerosis in pediatric patients.

President Trump today called for "tougher negotiation, more competition, and much lower prices at the pharmacy counter," in a statement on lowering drug prices.

Top news of the day from across the health care landscape.

The recommendation means more men could be screened, now that the recommendation has been upgraded from its existing D recommendation to a grade C recommendation.

Top news of the week from Specialty Pharmacy Times.

Researchers found that women with advanced triple-negative breast cancer who had inherited a BRCA mutation benefited more from the chemotherapy carboplatin than standard treatment.

A new study examines how chemoresistance evolves over time, which could lead to improved patient outcomes and survival.

According to the case study, an acute myeloid leukemia patient has remained cancer free for 9 months following treatment with the chimeric antigen receptor (CAR) T-cell treatment, CYAD-01, and a bone marrow transplant.

Top news of the day from across the health care landscape.

John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, discusses how data aggregators work with pharmacies and manufacturers to boost patient support services.

Text messages proactively gauge patients' struggle with opioid addiction to prevent relapse.

A dual immune-checkpoint blockade efficiently controlled the development of chronic lymphocytic leukemia by restoring functional antitumor immune response.

Luis Torres, MBA, vice president, Managed Care, BioPlus Specialty Pharmacy, discusses the importance of co-pay assistance programs for costly specialty drugs.

Top news of the day from across the health care landscape.

Rates of hospital inpatient admissions before and during use of ivacaftor found that overall and cystic fibrosis-related inpatient admissions fell by 55% and 81%, respectively.

The development and uptake of antiretroviral therapy for HIV has reduced the risk of certain cancers were previously prevalent.

Only a small portion of latently infected cells are reactivated by latency-reversing agents.

RBP-7000 is an investigational, subcutaneously administered extended-release treatment for schizophrenia.

Christopher W. Kennedy, MSM, Chief Operating Officer, Heritage Biologics, discusses how data can translate to improvements in patient care.

Top news of the day from across the health care landscape.

Artificial intelligence could take over medication dispensing in the next 50 years.

Kansas sought to cap Medicaid benefits at 3 years, a proposal that health care providers, hospitals, and advocates called cruel.

Pharmacy information systems streamline and standardize the data entry process, reduce errors, and save countless hours of labor.

Top news of the day from across the health care landscape.

The combination therapy dabrafenib plus trametinib approved for the treatment of BRAF V600 mutation-positive anaplastic thyroid cancer that cannot be removed by surgery or is metastatic.